F
Faris Madanat
Researcher at King Hussein Cancer Center
Publications - 16
Citations - 744
Faris Madanat is an academic researcher from King Hussein Cancer Center. The author has contributed to research in topics: Cancer & Acute leukemia. The author has an hindex of 8, co-authored 16 publications receiving 630 citations. Previous affiliations of Faris Madanat include King Hussein Medical Center.
Papers
More filters
Journal ArticleDOI
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Stella G. Muthuri,Sudhir Venkatesan,Puja R. Myles,Jo Leonardi-Bee,Tarig Saleh Al Khuwaitir,Adbullah Al Mamun,Ashish P Anovadiya,Eduardo Azziz-Baumgartner,Clarisa Báez,Matteo Bassetti,Bojana Beović,Barbara Bertisch,Isabelle Bonmarin,Robert Booy,Víctor Hugo Borja-Aburto,Heinz Burgmann,Bin Cao,Jordi Carratalà,Justin T Denholm,Samuel R. Dominguez,Péricles Almeida Delfino Duarte,Gal Dubnov-Raz,Marcela Echavarria,Sergio Fanella,Zhancheng Gao,Patrick Gérardin,Maddalena Giannella,Sophie Gubbels,Jethro Herberg,A. Iglesias,Peter Höger,Xiaoyun Hu,Quazi Tarikul Islam,Mirela Foresti Jiménez,Amr Kandeel,Gerben Keijzers,Hossein Khalili,Marian Knight,Koichiro Kudo,Gabriela Kusznierz,Ilija Kuzman,Arthur M C Kwan,Idriss Lahlou Amine,Eduard Langenegger,Kamran Bagheri Lankarani,Yee-Sin Leo,Rita Linko,Pei Liu,Faris Madanat,Elga Mayo-Montero,Allison McGeer,Ziad A. Memish,Gökhan Metan,Auksė Mickiene,Dragan Mikić,Kristin G.-I. Mohn,Kristin G.-I. Mohn,Ahmadreza Moradi,Ahmadreza Moradi,Pagbajabyn Nymadawa,Maria E. Oliva,Mehpare Ozkan,Dhruv Parekh,Mical Paul,Fernando P. Polack,Barbara Rath,Alejandro Rodríguez,Elena B. Sarrouf,Anna C. Seale,Anna C. Seale,Bunyamin Sertogullarindan,Marilda M. Siqueira,Joanna Skręt-Magierło,Frank P. Stephan,Ewa Talarek,Julian W. Tang,Julian W. Tang,Kelvin K. W. To,Antoni Torres,Selda Hançerli Törün,Dat Tran,Timothy M. Uyeki,Annelies van Zwol,Wendy Vaudry,Tjasa Vidmar,Renata T. C. Yokota,Paul Zarogoulidis,Jonathan S. Nguyen-Van-Tam +87 more
TL;DR: There was an increase in the mortality hazard rate with each day's delay in initiation of treatment up to day 5 as compared with treatment initiated within 2 days of symptom onset, and early treatment versus no treatment was also associated with a reduction in mortality risk.
Journal ArticleDOI
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis
Stella G. Muthuri,Sudhir Venkatesan,Puja R. Myles,Jo Leonardi-Bee,Wei Shen Lim,Abdullah Al Mamun,Ashish P Anovadiya,Wildo Navegantes de Araújo,Eduardo Azziz-Baumgartner,Clarisa Báez,C. Bantar,Mazen M. Barhoush,Matteo Bassetti,Bojana Beović,Roland Bingisser,Isabelle Bonmarin,Víctor Hugo Borja-Aburto,Bin Cao,Jordi Carratalà,María R. Cuezzo,Justin T Denholm,Samuel R. Dominguez,Péricles Almeida Delfino Duarte,Gal Dubnov-Raz,Marcela Echavarria,Sergio Fanella,James Fraser,Zhancheng Gao,Patrick Gérardin,Maddalena Giannella,Sophie Gubbels,Jethro Herberg,A. Iglesias,Peter H. Hoeger,Matthias Hoffmann,Xiaoyun Hu,Quazi Tarikul Islam,Mirela Foresti Jiménez,Amr Kandeel,Gerben Keijzers,Hossein Khalili,Gulam Khandaker,Marian Knight,Gabriela Kusznierz,Ilija Kuzman,Arthur M C Kwan,Idriss Lahlou Amine,Eduard Langenegger,Kamran Bagheri Lankarani,Yee Sin Leo,Rita Linko,Pei Liu,Faris Madanat,Toshie Manabe,Elga Mayo-Montero,Allison McGeer,Ziad A. Memish,Gökhan Metan,Dragan Mikić,Kristin G.-I. Mohn,Kristin G.-I. Mohn,Ahmadreza Moradi,Ahmadreza Moradi,Pagbajabyn Nymadawa,Bülent Özbay,Mehpare Ozkan,Dhruv Parekh,Mical Paul,Wolfgang Poeppl,Fernando P. Polack,Barbara Rath,Alejandro Rodríguez,Marilda M. Siqueira,Joanna Skręt-Magierło,Ewa Talarek,Julian W. Tang,Julian W. Tang,Antoni Torres,Selda Hançerli Törün,Dat Tran,Timothy M. Uyeki,Annelies van Zwol,Wendy Vaudry,Daiva Velyvyte,Tjasa Vidmar,Paul Zarogoulidis,Jonathan S. Nguyen-Van-Tam +86 more
TL;DR: The objective was to investigate the association between NAI treatment and IRP incidence and outcomes in patients hospitalised with A(H1N1)pdm09 virus infection.
Journal ArticleDOI
Outcome of childhood acute lymphoblastic leukemia in Jordan.
TL;DR: This study is designed to assess survival of childhood ALL at King Hussein Cancer Center (KHCC) using modified St. Jude Children's Research Hospital protocols.
Journal ArticleDOI
Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: A prospective multi‐institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA)
Naima Al-Mulla,Prem Chandra,M. Khattab,Faris Madanat,Parvaneh Vossough,Eyad Torfa,Zakiya Al-Lamki,Gamal Zain,Samar Muwakkit,Salah Mahmoud,Abdulrahman Mohd AlJassmi,Murat Tuncer,Hussein Al-Mukharraq,Sihem Barsaoui,Robert J. Arceci,Scott C. Howard,Andreas E. Kulozik,Yaddanapudi Ravindranath,Gregory H. Reaman,Mohammad Farranoush,Abdullah A Al-Nasser +20 more
TL;DR: This study was undertaken by MECCA as initial efforts in collaborative data collection to provide clinical and demographic information on children with ALL in the Middle East.
Journal ArticleDOI
Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia.
Lika’a Fasih Y. Al-Kzayer,Kazuo Sakashita,Mazin Faisal Al-Jadiry,Salma Abbas Al-Hadad,Hasanein H. Ghali,Le T.N. Uyen,Tingting Liu,Kazuyuki Matsuda,Jaafar M.H. Abdulkadhim,Tariq Abadi Al-Shujairi,Zead Ismael I.K. Matti,Maher A. Sughayer,Rawad Rihani,Faris Madanat,Toshi Inoshita,Minoru Kamata,Kenichi Koike +16 more
TL;DR: In this article, the frequency of RAS mutations and the association between RAS mutation and other genetic aberrations in Arab Asian children with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) were determined.